FMCCX | VSEMX | FMCCX / VSEMX | |
Total Expense Ratio | 0.68 | 0.02 | 3,400% |
Annual Report Gross Expense Ratio | 0.68 | 0.02 | 3,400% |
Fund Existence | 29 years | 9 years | - |
Gain YTD | -0.686 | -2.325 | 29% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.2B | 108B | 2% |
Annual Yield % from dividends | 0.52 | 1.24 | 42% |
Returns for 1 year | 4.07 | 10.38 | 39% |
Returns for 3 years | 22.65 | 43.02 | 53% |
Returns for 5 years | 44.53 | 63.97 | 70% |
Returns for 10 years | 31.04 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 66.74 | -0.42 | -0.63% |
Janus Henderson Global Life Sciences D | |||
EVSYX | 24.75 | -0.27 | -1.08% |
Allspring Disciplined US Core Admin | |||
SAOTX | 10.72 | -0.12 | -1.11% |
AllianceBern Overlay A 2 | |||
RLEOX | 11.63 | -0.16 | -1.36% |
Lazard Emerging Markets Core Equity R6 | |||
SLLAX | 12.28 | -0.22 | -1.76% |
SEI Small Cap F (SIMT) |